Peng Y, Yang H, Zhu T, Zhao M, Deng Y, Liu B, Shen H, Hu G, Wang Z, Tao L. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. Eur J Clin Invest. 2013 Apr; 43(4): 358-68.
发布时间：2020-07-28
点击次数：
是否译文：否
上一条： Peng Y, Yang H, Wang N, Ouyang Y, Yi Y, Liao L, Shen H, Hu G, Wang Z, Tao L. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2014 Feb; 306(3):G253-63.
下一条： Li YN, Shen H, Frank J. Burczynski, GONG YW. Prospect of bone morphogenetic protein 13 in liver diseases (In English). 中南大学学报（医学版）. 2012 Jan; 2012, 37(1): 1-5.